The round, which surpassed RxFunction’s initial $5 million funding goal, was led by Edina, Minn.–based Cedar Point Capital, a boutique investment banking firm.
The money will help RxFunding through FDA registration, funding the next clinical trial in the U.S., and building the organization so that it is ready for commercialization.
Get the full story on our sister site MassDevice.
The post RxFunction raises $7.5 million for its wearable sensory prosthesis appeared first on MassDevice.
from MassDevice https://ift.tt/2HaTMZw
Cap comentari:
Publica un comentari a l'entrada